What does the FDA’s hydroxychloroquine decision mean for Covid-19 patients or politicians? And 4 other burning questions
WASHINGTON — The Food and Drug Administration on Monday revoked its already controversial emergency use decision for the malaria drug hydroxychloroquine — an eyebrow-raising reversal that has sweeping implications for how America responds to Covid-19.
The decision, which flies in the face of President Trump’s own touting of the medicine as a treatment for Covid-19, is more than just a stunning rebuke of a president by his own administration. In fact, the decision is likely to impact everyone from governors who scrambled to assemble stockpiles of the drug for their states, to patients asking their family physician for a chance to try the drug.
